Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125245412 | 12524541 | 2 | F | 20160526 | 20160713 | 20160704 | 20160722 | EXP | PHHY2016IT088763 | SANDOZ | 86.54 | YR | F | Y | 57.00000 | KG | 20160722 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125245412 | 12524541 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 5 MG, QD | 201588 | 5 | MG | QD | |||||||
| 125245412 | 12524541 | 2 | I | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 125245412 | 12524541 | 3 | I | AMIODARONE | AMIODARONE | 1 | Intravenous (not otherwise specified) | Y | 0 | ||||||||||
| 125245412 | 12524541 | 4 | I | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | TABLET | QD | ||||||
| 125245412 | 12524541 | 5 | C | COUMADINE | WARFARIN SODIUM | 1 | Oral | U | 0 | TABLET | |||||||||
| 125245412 | 12524541 | 6 | C | HALCION | TRIAZOLAM | 1 | Oral | 125 UG, UNK | U | 0 | 125 | UG | TABLET | ||||||
| 125245412 | 12524541 | 7 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 50 MG, UNK | U | 0 | 50 | MG | COATED TABLET | ||||||
| 125245412 | 12524541 | 8 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 1.25 MG, UNK | U | 0 | 1.25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125245412 | 12524541 | 1 | Product used for unknown indication |
| 125245412 | 12524541 | 2 | Product used for unknown indication |
| 125245412 | 12524541 | 3 | Atrial fibrillation |
| 125245412 | 12524541 | 4 | Product used for unknown indication |
| 125245412 | 12524541 | 5 | Product used for unknown indication |
| 125245412 | 12524541 | 6 | Product used for unknown indication |
| 125245412 | 12524541 | 7 | Product used for unknown indication |
| 125245412 | 12524541 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125245412 | 12524541 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125245412 | 12524541 | Drug interaction | |
| 125245412 | 12524541 | Electrocardiogram QT prolonged | |
| 125245412 | 12524541 | Extrasystoles | |
| 125245412 | 12524541 | Torsade de pointes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125245412 | 12524541 | 3 | 20160526 | 20160526 | 0 |